Erasca (ERAS)
(Real Time Quote from BATS)
$3.03 USD
-0.04 (-1.30%)
Updated Sep 12, 2024 10:50 AM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for Erasca, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 142 | 247 | 125 | 109 | 0 |
Income After Depreciation & Amortization | -142 | -247 | -125 | -109 | 0 |
Non-Operating Income | 16 | 5 | 2 | 8 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -125 | -243 | -123 | -102 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -125 | -243 | -123 | -102 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -125 | -243 | -123 | -102 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -145 | -246 | -124 | -109 | 0 |
Depreciation & Amortization (Cash Flow) | -3 | 2 | 1 | 1 | NA |
Income After Depreciation & Amortization | -142 | -247 | -125 | -109 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 150.19 | 122.03 | 66.29 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.83 | -1.15 | -1.66 | NA | NA |
Diluted Net EPS (GAAP) | -0.83 | -1.99 | -1.85 | NA | NA |
Fiscal Year end for Erasca, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 67.78 | 38.85 | 33.88 | 34.66 | 35.97 |
Income After SG&A, R&D, and Dept/Amort Expenses | -67.78 | -38.85 | -33.88 | -34.66 | -35.97 |
Non-Operating Income | 4.58 | 3.83 | 4.17 | 4.30 | 4.19 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -63.20 | -35.02 | -29.70 | -30.36 | -31.78 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -63.20 | -35.02 | -29.70 | -30.36 | -31.78 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -63.20 | -35.02 | -29.70 | -30.36 | -31.78 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 217.81 | 151.16 | 150.73 | 150.45 | 150.04 |
Diluted EPS Before Non-Recurring Items | -0.29 | -0.23 | -0.20 | -0.20 | -0.21 |
Diluted Net EPS (GAAP) | -0.29 | -0.23 | -0.20 | -0.20 | -0.21 |